美国生物医药产业竞争力分析与启示  

Competitiveness Analysis and Enlightenment of Biomedical Industry in USA

作　　者：尹政清 白京羽[2] 林晓锋 YIN Zheng-qing;BAI Jing-yu;LIN Xiao-feng(College of Information and Electrical Engineering,China Agricultural University,Beijing 100083,China;Innovation Driven Development Center,National Development and Reform Commission,Beijing 100037,China)

机构地区：[1]中国农业大学信息与电气工程学院,北京100083 [2]国家发展和改革委员会创新驱动发展中心,北京100037

出　　处：《中国生物工程杂志》2020年第9期87-94,共8页China Biotechnology

摘　　要：进入生物经济时代以来,以生物医药产业为代表的生物技术产业正在引领人类新一波技术产业革命。我国针对生物医药产业作出的战略部署已经取得了明显成效,但与美国等生物医药强国相比仍有较大的竞争差距。采用波特钻石模型构建了生物医药产业国际竞争力理论分析框架,以美国为例分析其生物医药产业在要素状况、企业结构和竞争、需求条件、相关及支持性产业、政府和发展机会六个方面的竞争优势,并基于此提出了我国发展生物医药产业的政策建议,从而为我国生物医药产业发展提供政策参考。Represented by the biomedical industry,the bio-industry is leading a new wave of technological industry revolution since mankind entered the era of bioeconomy.China’s strategic deployment for the biopharmaceutical industry has achieved significant results.However,it still has a large competitive gap compared with the powerhouses of biomedical industry such as the United States.The Porter’s diamond model is employed to construct a conceptual framework for the international competitiveness of the biomedical industry,taking the United States as an example to analyze its biomedical industry from six perspectives:(1)Factor conditions;(2)Enterprise structure and competition;(3)Demand conditions;(4)Related and supporting industries;(5)The role of government;(6)Development opportunities.Finally,related policy recommendations for China’s biomedical industry development are put forward,so as to provide policy reference for the development of China’s biomedical industry.

关 键 词：生物医药产业 美国 国际竞争力 波特钻石模型 政策建议 

分 类 号：R-1[医药卫生]